Kankaanranta H - Search Results

1

Bringing asthma care into the twenty-first century.

Larsson K, Kankaanranta H, Janson C, Lehtimäki L, Ställberg B, Løkke A, Høines K, Roslind K, Ulrik CS. Larsson K, et al. Among authors: kankaanranta h. NPJ Prim Care Respir Med. 2020 Jun 5;30(1):25. doi: 10.1038/s41533-020-0182-2. NPJ Prim Care Respir Med. 2020. PMID: 32503985 Free PMC article. Review.

2

Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates.

Lehtimäki L, Turjanmaa V, Kankaanranta H, Saarelainen S, Hahtola P, Moilanen E. Lehtimäki L, et al. Among authors: kankaanranta h. Ann Med. 2000 Sep;32(6):417-23. doi: 10.3109/07853890008995949. Ann Med. 2000. PMID: 11028690

3

Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation.

Lehtimäki L, Kankaanranta H, Saarelainen S, Hahtola P, Järvenpää R, Koivula T, Turjanmaa V, Moilanen E. Lehtimäki L, et al. Among authors: kankaanranta h. Am J Respir Crit Care Med. 2001 Jun;163(7):1557-61. doi: 10.1164/ajrccm.163.7.2010171. Am J Respir Crit Care Med. 2001. PMID: 11401873

4

Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma.

Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Lehtimäki L, et al. Among authors: kankaanranta h. Eur Respir J. 2001 Oct;18(4):635-9. doi: 10.1183/09031936.01.00000201. Eur Respir J. 2001. PMID: 11716167 Free article.

5

Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms.

Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Lehtimäki L, et al. Among authors: kankaanranta h. Eur Respir J. 2002 Oct;20(4):841-5. doi: 10.1183/09031936.02.00202002. Eur Respir J. 2002. PMID: 12412673 Free article.

6

Peripheral inflammation in patients with asthmatic symptoms but normal lung function.

Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Lehtimäki L, et al. Among authors: kankaanranta h. J Asthma. 2005 Sep;42(7):605-9. doi: 10.1080/02770900500294678. J Asthma. 2005. PMID: 16169798

7

Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis.

Lehtonen H, Oksa P, Lehtimäki L, Sepponen A, Nieminen R, Kankaanranta H, Saarelainen S, Järvenpää R, Uitti J, Moilanen E. Lehtonen H, et al. Among authors: kankaanranta h. Thorax. 2007 Jul;62(7):602-7. doi: 10.1136/thx.2006.067868. Epub 2007 Jan 24. Thorax. 2007. PMID: 17251310 Free PMC article.

8

Bronchial diffusing capacity of nitric oxide is increased in patients with allergic rhinitis.

Makinen T, Lehtimäki L, Kinnunen H, Nieminen R, Kankaanranta H, Moilanen E. Makinen T, et al. Among authors: kankaanranta h. Int Arch Allergy Immunol. 2009;148(2):154-60. doi: 10.1159/000155746. Epub 2008 Sep 19. Int Arch Allergy Immunol. 2009. PMID: 18802360

9

Alveolar and bronchial nitric oxide output in healthy children.

Sepponen A, Lehtimäki L, Huhtala H, Kaila M, Kankaanranta H, Moilanen E. Sepponen A, et al. Among authors: kankaanranta h. Pediatr Pulmonol. 2008 Dec;43(12):1242-8. doi: 10.1002/ppul.20953. Pediatr Pulmonol. 2008. PMID: 19009623

10

Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD.

Lehtimäki L, Kankaanranta H, Saarelainen S, Annila I, Aine T, Nieminen R, Moilanen E. Lehtimäki L, et al. Among authors: kankaanranta h. Eur Respir J. 2010 Jan;35(1):72-8. doi: 10.1183/09031936.00177508. Epub 2009 Jul 2. Eur Respir J. 2010. PMID: 19574327 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page